FDA Dietary Supplement Labeling: What New Regulation Means for Consumer Safety

How Does the FDA Regulate Dietary Supplement Labels?

Under the Dietary Supplement Health and Education Act (DSHEA) of 1994, dietary supplements occupy a unique regulatory space. Unlike prescription and over-the-counter drugs, supplements do not require FDA pre-market approval for safety or efficacy. Manufacturers are permitted to make so-called structure/function claims — statements describing how a product affects the body's structure or function — without demonstrating clinical proof to the FDA beforehand. They must, however, include a disclaimer stating the claims have not been evaluated by the FDA.

Qualified health claims and authorized health claims represent a higher tier of labeling, where manufacturers assert a relationship between a substance and a disease or health condition. These require varying levels of FDA review and scientific substantiation. The distinction matters: a supplement can legally say it 'supports immune health' (structure/function claim) but cannot claim to 'prevent influenza' (disease claim) without FDA authorization. Critics argue this framework leaves consumers vulnerable to misleading marketing, while industry groups contend that DSHEA strikes a reasonable balance between access and oversight.

What Are the Risks of Inadequate Supplement Labeling Oversight?

Multiple investigations by the FDA, the Government Accountability Office (GAO), and independent researchers have found that a significant proportion of dietary supplements contain ingredients not listed on the label, or contain quantities that differ from what is claimed. The FDA has issued hundreds of warning letters and product recalls related to tainted supplements — particularly weight loss, sexual enhancement, and bodybuilding products — that were found to contain undeclared pharmaceutical ingredients. These adulterants can cause serious adverse effects, especially in people taking prescription medications.

The challenge is compounded by the sheer scale of the market. The FDA has acknowledged it lacks the resources to test or inspect more than a fraction of the estimated tens of thousands of supplement products sold in the United States. The agency primarily relies on post-market surveillance and adverse event reporting, meaning problems are often identified only after consumers have been harmed. Public health experts, including researchers writing in journals such as JAMA and The New England Journal of Medicine, have called for modernizing the regulatory framework to require at minimum product registration, ingredient verification, and stricter enforcement of good manufacturing practices.

What Changes Are Being Considered for Supplement Regulation?

Legislative proposals have periodically emerged in Congress to strengthen FDA oversight of dietary supplements. Among the most discussed measures is mandatory product listing, which would require all supplement manufacturers to register their products and ingredients with the FDA — a basic step that is not currently required under DSHEA. Bipartisan support has grown for such measures, with proponents arguing that a product registry would allow the FDA to identify and act against dangerous products more quickly.

Beyond registration, some proposals call for mandatory third-party testing to verify that products contain what their labels claim, and that they are free of contaminants such as heavy metals, pesticides, and undeclared drugs. The Council for Responsible Nutrition (CRN), a major industry trade group, has expressed support for mandatory product listing, signaling that parts of the industry recognize the need for greater transparency. For consumers, health professionals recommend choosing supplements that carry voluntary third-party certification seals from organizations such as USP (United States Pharmacopeia), NSF International, or ConsumerLab, which independently verify product contents.